According to FutureWise analysis, the market for Radiofrequency Ablation Devices in 2023 is US$ 4.82 billion, and is expected to reach US$ 12.04 billion by 2031 at a CAGR of 12.10%.
A medical treatment known as radiofrequency ablation (RFA) uses heat radiation to reduce the size of tumors and other growths in the body or to relieve discomfort. Numerous medical disorders, such as benign or malignant tumors, persistent neck or back pain, and chronic venous insufficiency felt in the legs, are treated using this method. The procedure necessitates the introduction of a needle-like probe into the patient's body and is quite similar to a needle biopsy. The radiofrequency waves are transmitted from the probe to the surrounding tissue in the targeted area after the device has been firmly and precisely placed. The cells in the area eventually die. Once the cells have died, the immune system begins to remove them from the body, which causes an internal reaction and causes the nodule size to decrease.
The procedure is patient-friendly because it is minimally invasive, does not require a lengthy recovery period, and can be carried out in a typical hospital setting or the patient's home. The patient can proceed with normal daily activities within 24-30 hours of the procedure's completion. Due to a rise in cancer patients and the associated increase in research and development and investments in cancer treatments, the market for radiofrequency ablation devices is expected to expand globally. Most commonly, cancers of the kidney, lungs, liver, adrenal gland, thyroid, and pancreas are treated using the RFA approach.
FutureWise Market Research has published a report that provides an insightful analysis of radiofrequency ablation devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, the radiofrequency ablation devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.